Skip to main content
PLOS One logoLink to PLOS One
. 2013 Jul 3;8(7):e67919. doi: 10.1371/journal.pone.0067919

Proteomic Evaluation of Acquired Enamel Pellicle during In Vivo Formation

Young Ho Lee 1, Jason N Zimmerman 1, William Custodio 1, Yizhi Xiao 1, Tayebeh Basiri 1, Sahza Hatibovic-Kofman 1, Walter L Siqueira 1,*
Editor: Anthony George2
PMCID: PMC3700865  PMID: 23844127

Abstract

Acquired enamel pellicle (AEP) is a protein film that forms on the enamel surface of teeth by selective adsorption of proteins and peptides present in the mouth. This protein film forms the interface between enamel and the damage oral biofilm, which modulates the attachment of bacteria found in oral biofilm. The overall goal of this study was to gain insight into the biological formation of the human in vivo AEP. This study hypothesized that AEP is created by the formation of successive protein layers, which consist of initial binding to enamel and subsequent protein-protein interactions. This hypothesis was examined by observing quantitative and qualitative changes in pellicle composition during the first two hours of AEP formation in the oral cavity. Quantitative mass spectrometry approaches were used to generate an AEP protein profile for each time-point studied. Relative proteomic quantification was carried out for the 50 proteins observed in all four time-points. Notably, the abundance of important salivary proteins, such as histatin 1, decrease with increasing of the AEP formation, while other essential proteins such as statherin showed constant relative abundance in all time-points. In summary, this is the first study that investigates the dynamic process to the AEP formation by using proteomic approaches. Our data demonstrated that there are significant qualitative and quantitative proteome changes during the AEP formation, which in turn will likely impact the development of oral biofilms.

Introduction

The composition of the acquired enamel pellicle (AEP) formed in vivo has been studied by many techniques, including microscopy [1], amino acid analysis [2], [3], gel-filtration and ion-exchange chromatography [4], [5], and electrophoresis and immunoblotting [6], [7], [8], [9], [10], [11], [12]. All of these studies have been limited by the difficulties encountered in obtaining adequate amounts of AEP material for classical biochemical characterization [13]. However, a consistent finding has been that the amino acid compositions of pellicles from different subjects are remarkably similar [3]. Recent developments of sensitive proteomic methodologies have opened new avenues for the characterization of very-low-abundance biological samples such as AEP. Using this proteomic technology, studies have been carried out to explore the composition of in vitro [14], [15], in situ [16], [17] and in vivo AEP [15], [18]. As a results of this novel technology, our group have used mass spectrometry to perform the first global proteome of human pellicle [19]. We have successfully identified 130 AEP proteins, which have been characterized according to origin, putative biological function and possible role in AEP structure. A surprising finding was that only 14% of the identified proteins were derived from exocrine salivary secretions. Most of the identified pellicle proteins originated from the non-exocrine contributors to whole saliva, comprising epithelial cells (68%) and serum (18%). The latter oral fluid contributor enters the oral cavity through the gingival crevice.

When the 130 proteins were categorized based on their possible role in AEP formation, three main groups, together adding up to 61% of all proteins were identified. The first group consist of proteins that have the ability to bind calcium ions, comprising 18% of the identified AEP proteins. Among these are the acidic PRPs and histatins, both proteins originating from exocrine salivary secretions. The second group (15%) consists of proteins that show a high tendency to bind phosphate ions, such as elongation factor 2 and myosin-9, both proteins are derived from epithelial cells. The third group (28%) consists of proteins that have been described to have interactions with other proteins. An example is MUC5B, which has been described to form complexes with several other salivary proteins, including salivary α-amylase, histatin and statherin [20], [21].

We hypothesize that in vivo AEP pellicle is created by the formation of successive protein layers, based initially on binding to tooth mineral (calcium and phosphate) and subsequently on protein-protein interaction. This working hypothesis will be examined by assessing quantitative and qualitative changes in AEP composition during the first two hours of formation in the oral cavity. Quantitative mass spectrometry approach will be performed to generate an AEP protein profile for each time-point studied. We expect to identify and characterize the particular proteome profiles for the initial and final stages of AEP formation, where proteins or peptides with affinity to hydroxyapatite will be more abundant in the first stages of AEP formation, and the remaining AEP components will be subsequently incorporated into the pellicle film.

Methods

Acquired Enamel Pellicle Collection

This study was approved by the Research Human Ethics Board of the University of Western Ontario (review number 16181E). Written informed consent was acquired from all subjects in this study. AEP were collected from 7 patients including 4 male and 3 female (aged 20 to 30 years old). The participants were healthy individuals who did not have systemic and oral diseases. The samples were collected between 9 am and 11 am. Subjects were not allowed to eat or drink 2 hours before the sample collection. Each participant was subjected to dental prophylaxis in order to remove the previous existing AEP. Subsequently, they were asked to wait for each time-points in order for AEP to form on the enamel surface. Four different time-points were used in the current study; including 5, 10, 60, and 120 min. The collections were carried out as described before [22] on different days for each time-point using the same volunteers. After collecting, the samples were kept at –80°C.

AEP Elution from Collection Strips via Sonication

All collection strips were pooled into a 15 mL Falcon tube. Pool samples from each time-point were kept separately. Three mL of 50 mM NH4HCO3, pH 7.8 were added into the tubes until all the strips were submerged by the solution. Subsequently, the samples were sonicated at room temperature for 1 min. The supernatants were collected and dried in a rotary evaporator. Micro-BCA was performed to measure the total protein concentration from each AEP time-point.

In–Solution Digestion

Equal protein amount (20 µg) from each time-point group was dried by a rotary evaporator, denatured and reduced for 2 h by the addition of 200 µl of 4 M urea, 10 mM dithiothreitol (DTT), and 50 mM NH4HCO3, pH 7.8. After four-fold dilution with 50 mM NH4HCO3, pH 7.8, tryptic digestion was carried overnight at 37°C, after the addition of 2% (w/w) sequencing-grade trypsin (Promega, Madison, WI, USA). After protein digestion period the samples were completely dried to stop the enzymatic reaction.

Liquid Chromatography Electrospray Ionization Tandem Mass Spectrometry (LC-ESI-MS/MS)

Peptide separation and mass spectrometric analyses were carried out with a nano-HPLC Proxeon (Thermo Scientific, San Jose, CA, USA) which allows in-line liquid chromatography with the capillary column, 75 µm X 10 cm (Pico Tip™ EMITTER, New Objective, Woburn, MA) packed in-house using Magic C18 resin of 3 µm diameter and 200 Å pores size (Michrom BioResources, Auburn, CA) linked to mass spectrometer (LTQ-Velos, Thermo Scientific, San Jose, CA, USA) using an electrospray ionization in a survey scan in the range of m/z values 390–2000 tandem MS/MS. Equal amount of all samples (20 µg/each group) were re-suspended in 20 µl of 97.5% H2O/2.4% acetonitrile/0.1% formic acid and then subjected to reversed-phase LC-ESI-MS/MS. The nano-flow reversed-phase HPLC was developed with linear 80 minutes gradient ranging from 5% to 55% of solvent B in 65 minutes (97.5% acetonitrile, 0.1% formic acid) at a flow rate of 300 nl/min with a maximum pressure of 280 bar. Electrospray voltage and the temperature of the ion transfer capillary were 1.8 kV and 250°C respectively. Each survey scan (MS) was followed by automated sequential selection of seven peptides for CID, with dynamic exclusion of the previously selected ions.

The obtained MS/MS spectra were searched against human protein databases (Swiss Prot and TrEMBL, Swiss Institute of Bioinformatics, Geneva, Switzerland, http://ca.expasy.org/sprot/) using SEQUEST algorithm in Proteome Discoverer 1.3 software (Thermo Scientific, San Jose, CA, USA). Search results were filtered for a False Discovery rate of 1% employing a decoy search strategy utilizing a reverse database. An additional inclusion criterion for positive identification of proteins was the same protein passing the filter score from at least in three different MS analyses from the same time-point group in a total of four MS analyses per group.

Integration and Relative Proteome Quantitation

For quantitative proteome analysis, three MS raw files from each pooled group were analyzed using SIEVE technology (Version 2.0 Thermo Scientific, San Jose, CA, USA). Signal processing was performed in a total of 12 MS raw files. The SIEVE experimental workflow was defined as “Control Compare Trend Analysis” where one class of samples was compared to one or more other class of samples. Here the control samples (5-min AEP period) were compared to each of the samples that were harvested in different time-point (10, 60 and 120 min). For the alignment step, a single MS raw file belonging to the 5-min AEP group was selected as the reference file and all of the other files were adjusted to generate the best correlation to this reference file. After alignment, the feature detection and integration (or framing) process was performed using the MS level data with a feature called “Frames From MS2 Scans” only. When using this type of framing only MS mass-to-charge ratio (m/z) values that were associated with MS2 scan were used. Any m/z measurements that did not have MS2 were ignored. The parameters used consisted of a frame m/z width of 1500 ppm and a retention time width of 1.75 min. A total of 73456 MS2 scans were present in all of the 12 RAW files that resulted in a total of 11151 frames. Then peak integration was performed for each frame and these values were used for statistic analysis. Next, peptide sequences obtained from the database search using SEQUEST algorithm in Proteome Discoverer 1.3 were imported into SIEVE. A filter was applied to the peptide sequences during the import that eliminated all sequences with a Percolator q-value greater than 1% (false discovery rate). Peptides were grouped into proteins and a protein ratio and p-value were calculated. SIEVE uses a weighted average of the peptide intensities for the protein calculation. By using the weighted average, peptides with lower variance in their intensity measurements have a higher weight on the overall protein ratio. This was done to decrease variance in protein level quantities based on variance of the peptides that compose proteins. Only proteins observed in all four time-point groups were quantified. 5-min AEP group was used as our default group and all other three groups were compared with 5-min AEP group.

Relative abundance of an individual protein from 5-min AEP group was considered significantly different protein level when the values observed were <0.75 for decrease abundance or >1.25 for increase abundance, and a p-value <0.05 as described [23].

Results

The peptide ions were identified by the SEQUEST search following the criteria as described in Methods. For the proteome identification of the AEP, formed in all four different time-points carried out in this study, a total of 89 different proteins were identified in 5-min AEP formation, 92 different proteins were identified in 10-min AEP formation, 107 different proteins were identified in 60-min AEP formation and 101 different proteins were identified in 120-min AEP formation (Table 1). The majority of the proteins were identified in all four groups indicating a high overlap in AEP proteins. Figure 1 shows a Venn diagram with the number of proteins from each group and their overlaps among the four groups. A total of 50 proteins were present in all four groups. Six proteins were exclusively present in 5-min AEP group. Four proteins were exclusively present in 10-min AEP group. Two proteins were exclusively present in 60-min AEP group and other 3 proteins were present only in 120-min AEP (Table 1; Figure 1).

Table 1. In vivo AEP proteins identified after 5, 10, 60 and 120-min pellicle formation.

Accession Number Protein Name Chemical properties*
Proteins present at all AEP time-points P23280 Carbonic anhydrase 6 Ca+2 and PO4 binding
Q9HCY8 Protein S100-A14 Ca+2 binding
P35527 Keratin type I cytoskeletal 9 protein-protein interaction
B4DRY0 cDNA FLJ54379 highly similar to Keratin type II cytoskeletal 6E protein-protein interaction
A8K2I0 cDNA FLJ78504 highly similar to Homo sapiens keratin 6A (KRT6A) mRNA
P13645 Keratin type I cytoskeletal 10 protein-protein interaction, Ca+2 and PO4 binding
C3PTT6 Pancreatic adenocarcinoma upregulated factor protein-protein interaction
B4DKJ0 cDNA FLJ58539 highly similar to Keratin type II cytoskeletal 4 protein-protein interaction
P06733 Alpha- Enolase Ca+2 and PO4 binding
B7WNW7 HEAT repeat containing protein 3 protein-protein interaction, Ca+2 and PO4 binding
P98088 Mucin 5A protein-protein interaction
P13646 Keratin, type I cytoskeletal 13
F8VV32 Lysozyme C protein-protein interaction, Ca+2 binding
B4DWU0 cDNA FLJ56791 highly similar to Keratin type I cytoskeletal 16 protein-protein interaction
P02812 Basic salivary proline rich protein 2 protein-protein interaction
P01034 Cystatin C protein-protein interaction, Ca+2 binding
P23284 Peptidyl prolyl cis trans isomerase B protein-protein interaction
Q01546 Keratin type II cytoskeletal 2 oral
Q4VAY2 PRB3 protein protein-protein interaction
Q6GMW3 IGL protein protein-protein interaction, Ca+2 binding
P27482 Calmodulin-like protein 3 Ca+2 binding
P02787 Serotransferin Ca+2 and PO4 binding
B4DDZ2 cDNA FLJ60419 highly similar to R3H domain containing protein 2
P28325 Cystatin D protein-protein interaction, Ca+2 binding
P15516 Histatin 3 Ca+2 binding
P06702 Calgranulin B Ca+2 binding
P02808 Statherin Ca+2 binding
Q5BQ95 Kallikrein 13 splice variant 7
Q9UGM3 Deleted in malignant brain tumors 1 protein(glycoprotein 340) protein-protein interaction
B4DYU5 cDNA FLJ50396 highly similar to Zinc finger and BTB domain containing protein 17
P04745 Alpha-amylase 1 protein-protein interaction, Ca+2 binding
P02647 Apolipoprotein A I Ca+2 binding
Q8IWA8 PCSK2 protein
Q9C0E4 Glutamate receptor interacting protein 2 protein-protein interaction, Ca+2 binding
Q9P273 Teneurin 3
P35908 Keratin type II cytoskeletal 2 epidermal protein-protein interaction, Ca+2 binding
P20061 Transcobalamin 1
F8W6D7 Protein CBFA2T2
P15515 Histatin 1 Ca+2 binding
P0C091 FRAS1 related extracellular matrix protein 3
F8W1S1 Keratin type II cytoskeletal 74
P09228 Cystatin SA Ca+2 binding
B4DF17 cDNA FLJ59187 highly similar to Multiple coagulation factor deficiency protein 2 homolog
P02768 Serum albumin protein-protein interaction
P12273 Prolactin inducible protein protein-protein interaction
P01036 Cystatin S Ca+2 binding
H0Y3I2 Lactoperoxidase protein-protein interaction
Q9UP60 SNC73 protein
P01833 Polymeric immunoglobulin receptor protein-protein interaction
P02810 Salivary acidic proline rich phosphoprotein 1/2 Ca+2 binding
Proteins present at 5-min, 10-min and 60-min AEP time-points P78333 Glypican-5
O75376 Nuclear receptor corepressor 1
Q9BZZ2 Sialoadhesin protein-protein interaction
A7MCY6 TANK-binding kinase 1-binding protein 1 protein-protein interaction
Q9Y3R5 Protein dopey-2
B3V0L1 ADP-ribosylation factor-like protein 6-interacting protein 4
P20061 Transcobalamin-1
B4DH81 cDNA FLJ61250, highly similar to Homo sapiens GTPase activating Rap/RanGAP domain-like 3
Q9BTC0 Death-inducer obliterator 1
E7EX20 Tubulin polyglutamylase TTLL4
O00444 Serine/threonine-protein kinase Ca+2 binding
Proteins present at 5-min, 10-min and 120-min AEP time-points P30622 CAP-Gly domain-containing linker protein 1
Q75T53 Putative uncharacterized protein
Proteins exclusively present at 5-min AEP time-point P01037 Cystatin-SN Ca+2 binding
Q5T3N0 Annexin (Fragment) Ca+2 and PO4 binding
P07339 Cathepsin D protein-protein interaction, Ca+2 binding
Q9UBC9 Small proline-rich protein 3 Ca+2 binding
P04080 Cystatin-B Ca+2 binding
P31949 calgizzarin(s-100calcium binding protein a11) Ca+2 binding
Proteins present at 5-min and 10-min AEP time-points Q9NZU7 Calcium-binding protein 1 Ca+2 binding
P02679 Fibrinogen gamma chain protein-protein interaction
Proteins present at 5-min and 60-min AEP time-points P62158 Calmodulin Ca+2 binding
Q06830 Peroxiredoxin-1 protein-protein interaction, Ca+2 binding
O75828 carbonyl reductase
Proteins present at 5-min and 120-min AEP time-points Q8TAX7 Mucin-7 protein-protein interaction
P02766 Transthyretin
P18135 Ig kappa chain V-III region HAH protein-protein interaction
Q9Y6R7 IgGFc-binding protein protein-protein interaction
A1L4B8 Myeloperoxidase Ca+2 and PO4 binding
P34931 Heat shock 70 kDa protein 1L
Proteins present at 5-min, 60-min and 120-min AEP time-points Q96S07 Proline-rich protein 25 Ca+2 binding
P05109 Protein S100-A8 Ca+2 binding
Q7Z2U7 Putative uncharacterized protein
Q6GMV8 Putative uncharacterized protein
P02765 Alpha-2-HS-glycoprotein protein-protein interaction
P17213 bacterial permeability-increasing protein protein-protein interaction
P11021 endoplasmic reticulum lumenal Ca binding protein Ca+2 binding
P01023 Alpha-2-macroglobulin protein-protein interaction
P08311 Cathepsin G protein-protein interaction, Ca+2 binding
P54108 Cysteine-rich secretory protein 3
Q01469 Fatty acid-binding protein protein-protein interaction
Proteins exclusively present in 10-min AEP time-point Q9Y6R7 IgGFc-binding protein protein-protein interaction
P20930 Filaggrin Ca+2 binding
Q96DR5 parotid secretory protein Ca+2 binding
O43240 Kallikrein-10 Ca+2 binding
Proteins present at 10-min and 60-min AEP time-points P10599 Thioredoxin
P09211 Glutathione S-transferase P
P80511 calgranulin C Ca+2 binding
P06703 S100 calcium-binding protein A6 Ca+2 binding
Proteins present at 10-min and 120-min AEP time-points B5ME49 Mucin-16 protein-protein interaction
P01009 Alpha-1-antitrypsin
P06733 Alpha-enolase protein-protein interaction, Ca+2 binding
P00738 Haptoglobin
Q96FQ6 Protein S100-A16 Ca+2 binding
Proteins present at 10-min, 60-min and 120-min AEP time-points F6KPG5 Albumin (Fragment) protein-protein interaction
H7C4X9 Protein kinase C-binding protein 1 (Fragment) Ca+2 binding
P10161 Basic salivary proline-rich protein 4 allele M (Fragment) protein-protein interaction
P04406 Glyceraldehyde-3-phosphate dehydrogenase protein-protein interaction
Q6GMX1 Immunoglobulin heavy variable 4–31 protein-protein interaction
P68871 Hemoglobin subunit beta protein-protein interaction
Q04118 Basic salivary proline-rich protein 3 protein-protein interaction
P25311 zinc-alpha-2-glycoprotein precursor protein-protein interaction, Ca+2 binding
P04280 Basic salivary proline-rich protein 1 protein-protein interaction
P02812 Basic salivary proline-rich protein 2 (Fragment) protein-protein interaction
P49913 Cathelicidin antimicrobial peptide protein-protein interaction, Ca+2 binding
P28676 Grancalcin Ca+2 binding
P11021 endoplasmatic reticulum lumenal Ca binding protein Ca+2 binding
P63104 protein kinase C inhibitor protein 1 Ca+2 binding
P02675 Fibrinogen beta chain precursor protein-protein interaction
P01876 Ig alpha-1 chain c region protein-protein interaction
Proteins exclusively present at 60-min AEP time-point D3DP16 Fibrinogen gamma chain, isoform CRA_a
B3W5Y6 Squamous cell carcinoma antigen-1 isoform SCCA-PD
Proteins present at 60-min and 120-min AEP time-points Q6WRI0 Immunoglobulin superfamily member 10 protein-protein interaction
P04083 Annexin A1 protein-protein interaction
P62736 Actin, aortic smooth muscle
P01024 Complement C3 protein-protein interaction
A5D903 PRB1 protein protein-protein interaction
Q96DR5 Short palate, lung and nasal epithelium carcinoma-associated protein 2 protein-protein interaction, Ca+2 binding
Q14568 Putative heat shock protein HSP 90-alpha A2 PO4 binding
E7EUT5 Glyceraldehyde-3-phosphate dehydrogenase protein-protein interaction
F5H308 L-lactate dehydrogenase
P01834 Ig kappa chain c protein-protein interaction
Proteins exclusively present at 120-min AEP time-point P02788 Lactotransferrin protein-protein interaction, Ca+2 and PO4 binding
P32926 Desmoglein-3 Ca+2 and PO4 binding
P12035 Keratin, type II cytoskeletal 3 protein-protein interaction
*

Sorting of the chemical properties of these proteins was based on their annotations in the UniProt protein database (www.uniprot.org) and EMBL-EBI database (www.ebi.ac.uk).

Figure 1. Venn diagram of AEP proteins identified in each time-point and across time-point.

Figure 1

Relative proteomic quantification was carried out in the 50 proteins observed in all AEP time-point groups. Differential display of MS/MS spectra was carried out using SIEVE software. A first step in the quantitative proteomic analysis by SIEVE was to promote an alignment of all mass spectrometry chromatograms. One of the mass spectrometry chromatogram was noted as default chromatogram (5-min AEP). All other chromatograms were compared with the default one. Coefficient correlation score values were acquired for each mass spectrometric chromatogram and mean score values were calculated for each group. The values were 0.831 to 10-min AEP group, 0.851 to 60-min AEP group and, 0.813 to 120-min AEP.

A threshold for significant differential level was set up at variation higher or lower than the 25% protein level observed in the control group. A total of 40 proteins showed a differential level between 5-min AEP group and 10-min AEP group where 22 showed a decrease level and 18 proteins showed an increase level. In addition, 19 proteins showed a decrease level between 5-min AEP group and 60-min AEP group and 17 proteins showed an increase level. Comparison of the 5-min AEP group with 120-min AEP group, demonstrated 24 proteins with a reduced protein level while 14 protein showed an increase (Table 2).

Pellicle proteins for each time-point were analyzed according to their role in AEP structure formation or molecular interaction; and the proteins were segregated into three main groups (Table 1; Figure 2). Overall, AEP proteins containing calcium and phosphate binding property were more predominant when the time-points 5-min and 10-min AEP formation was counted, between 50% and 85%, respectively (Table 1). While AEP proteins with protein-protein interaction property demonstrated a gradual increment according to the pellicle development (Figure 2).

Figure 2. Distribution of identified proteins according to their role in AEP structure formation or molecular interaction.

Figure 2

Discussion

One of the major achievements of this study was to obtain a broader insight into the protein pattern profile of the AEP during its first two hours formation. In this study, a state-of-the-art approach, label-free quantitative proteomics based on mass spectrometry, was used to investigate the precursor protein members present in the AEP and its behavior during the AEP formation. Interestingly, according to the pellicle development was happening, the measured alignment value was become more distant than the default chromatogram (5-min AEP, established score 1). This observation suggests a change in quantity and quality of protein/peptides according to the pellicle formation.

Both, histatin 1 and histatin 3 proteins demonstrated drastic reduction abundance after 60 and 120 minutes pellicle formation when compared with the first 5 minutes pellicle development (Figure 3A, B). Despite the high affinity of those proteins to the enamel surface, histatins are highly susceptible to proteolytic degradation [24], [25]. On the other hand, recent study has showed that histatin 1 when attached to the enamel surface; this protein is less susceptible to proteolytic degradation [26]. In our study, we observed a high abundance of these proteins in the initial stage of the pellicle formation (5-min AEP group), which can be correlated to the well-characterized features of these proteins to be the precursor protein in the formation of the AEP, but a significant reduction according to the time development of AEP. This observation can be related to the protein degradation susceptibility common observed in this protein family when in saliva or attached to the enamel surface.

Figure 3. Time course of changes in the abundance of specific AEP proteins.

Figure 3

(A) histatin 1, (B) histatin 3, (C) statherin, (D) acidic PRP1, (E) amylase, (F) MUC5B, (G) lysozyme, (H) lactoperoxidase. Note: * denotes statistical difference when compared with 5-min AEP time-point. p>0.05.

Other important salivary proteins such as statherin, that presents similar characteristics as histatins, has high affinity to hydroxyapatite and susceptible to proteolytic degradation when in saliva [27], has demonstrated a complete different pattern. Statherin relative protein abundance did not change during the time period for in vivo AEP development (Figure 3C). This finding indicates that statherin is a protein present in the first and final minutes of AEP formation with a similar abundance, suggesting that this protein is not highly susceptible to proteolytic degradation as histatins when bound to enamel; or this protein is not replaced by other proteins or peptides that are incorporated to AEP. However, our previous in vivo AEP peptidome study identified and characterized five naturally occurring statherin peptides ranging from N-terminal to C-terminal, demonstrating the presence of statherin peptides [22]. Similar phenomenon was observed with Cystatin D, where there was no significant abundance change according to the progress of AEP development. Other cystatins, such as cystatin S and SA demonstrated a different comportment, where these two proteins relatively increased in 10 and 60 minutes AEP formation, and relatively reduced in the last time period assessed.

Unexpected and interesting behavior was observed with acidic PRP1, a phosphoprotein that present a high affinity for hydroxyapatite and is potent inhibitor of secondary calcium phosphate precipitation, which is in large part due to their two phosphate groups linked covalently to Ser residues in position 8 and 22 [28]. This phosphoprotein showed a relative increase of 137% after 120-min AEP formation (Figure 3D). This observation is quite important since the predominant role of this protein family in the oral cavity is believed to be related to mineral homeostasis and the maintenance of tooth integrity.

Well-characterized salivary proteins such as amylase, MUC5B, lysozyme, and lactoperoxidase demonstrated a significant increase change according to the development of in vivo AEP (Figure 3E, F, G, H). All these proteins present protein-protein interaction features with other salivary proteins [20], [21]. This characteristic can justify the relative increase in the level of these proteins in the last stage of AEP formation, where for example these proteins can link to other proteins such as histatin 1. In this relation, recently we demonstrated that histatin 1 are able to interact with a total of 43 salivary proteins, including, amylase, MUC 5B, lysozyme, and lactoperoxidase [29].

In summary, this is the first study that investigates the dynamic process to the AEP formation by using proteomic approaches. In addition, this study demonstrated that there is a tendency for salivary proteins with affinity to calcium and phosphate be more abundant in the early stages of the AEP formation while proteins with recognized protein-protein interaction property is more significant in the final development of the AEP. Understanding pellicle formation is of great interest in the field of preventive dentistry due to pellicle serving as a solid support for the development of the plaque biofilm. Thus, it is reasonable to postulate that interference in the protein composition and structure of AEP during its formation could be a significant preventive approach. In the long term, these findings could be used to develop salivary substitutes and therapeutics for the control of biofilm growth and remineralization of early caries.

Funding Statement

This research was supported by the Natural Sciences and Engineering Research Council of Canada (NSERC grant #371813), the Canadian Institutes of Health Research, (CIHR grant #106657 and grant #97577), and the Canada Foundation for Innovation-Leaders Opportunity Fund (CFI-LOF grant #25116). WLS is recipient of a CIHR New Investigator Award (grant #113166). JNZ is recipient of an Ontario Dental Association (ODA) and CIHR Schulich Dentistry undergraduate dental student scholarship. YHL is recipient of a CIHR undergraduate scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1. Schupbach P, Oppenheim FG, Lendenmann U, Lamkin MS, Yao Y, et al. (2001) Electron-microscopic demonstration of proline-rich proteins, statherin, and histatins in acquired enamel pellicles in vitro. Eur J Oral Sci 109: 60–68. [DOI] [PubMed] [Google Scholar]
  • 2. Mayhall CW (1975) Studies on the composition of the enamel pellicle. Ala J Med Sci 12: 252–271. [PubMed] [Google Scholar]
  • 3. Rykke M, Sonju T, Rolla G (1990) Interindividual and longitudinal studies of amino acid composition of pellicle collected in vivo. Scand J Dent Res 98: 129–134. [DOI] [PubMed] [Google Scholar]
  • 4. Eggen KH, Rolla G (1982) Gel filtration, ion exchange chromatography and chemical analysis of macromolecules present in acquired enamel pellicle (2-hour-pellicle). Scand J Dent Res 90: 182–188. [DOI] [PubMed] [Google Scholar]
  • 5. Eggen KH, Rolla G (1983) Further studies on the composition of the acquired enamel pellicle. Scand J Dent Res 91: 439–446. [DOI] [PubMed] [Google Scholar]
  • 6. Kousvelari EE, Baratz RS, Burke B, Oppenheim FG (1980) Immunochemical identification and determination of proline-rich proteins in salivary secretions, enamel pellicle, and glandular tissue specimens. J Dent Res 59: 1430–1438. [DOI] [PubMed] [Google Scholar]
  • 7. Bennick A, Chau G, Goodlin R, Abrams S, Tustian D, et al. (1983) The role of human salivary acidic proline-rich proteins in the formation of acquired dental pellicle in vivo and their fate after adsorption to the human enamel surface. Arch Oral Biol 28: 19–27. [DOI] [PubMed] [Google Scholar]
  • 8. Al-Hashimi I, Levine MJ (1989) Characterization of in vivo salivary-derived enamel pellicle. Arch Oral Biol 34: 289–295. [DOI] [PubMed] [Google Scholar]
  • 9. Edgerton M, Levine MJ (1992) Characterization of acquired denture pellicle from healthy and stomatitis patients. J Prosthet Dent 68: 683–691. [DOI] [PubMed] [Google Scholar]
  • 10. Carlen A, Borjesson AC, Nikdel K, Olsson J (1998) Composition of pellicles formed in vivo on tooth surfaces in different parts of the dentition, and in vitro on hydroxyapatite. Caries Res 32: 447–455. [DOI] [PubMed] [Google Scholar]
  • 11. Li J, Helmerhorst EJ, Corley RB, Luus LE, Troxler RF, et al. (2003) Characterization of the immunologic responses to human in vivo acquired enamel pellicle as a novel means to investigate its composition. Oral Microbiol Immunol 18: 183–191. [DOI] [PubMed] [Google Scholar]
  • 12. Li J, Helmerhorst EJ, Troxler RF, Oppenheim FG (2004) Identification of in vivo pellicle constituents by analysis of serum immune responses. J Dent Res 83: 60–64. [DOI] [PubMed] [Google Scholar]
  • 13. Siqueira WL, Helmerhorst EJ, Zhang W, Salih E, Oppenheim FG (2007) Acquired enamel pellicle and its potential role in oral diagnostics. Annals of the New York Academy of Sciences 1098: 504–509. [DOI] [PubMed] [Google Scholar]
  • 14. Vitorino R, Lobo MJ, Duarte J, Ferrer-Correia AJ, Tomer KB, et al. (2004) In vitro hydroxyapatite adsorbed salivary proteins. Biochem Biophys Res Commun 320: 342–346. [DOI] [PubMed] [Google Scholar]
  • 15. Yao Y, Grogan J, Zehnder M, Lendenmann U, Nam B, et al. (2001) Compositional analysis of human acquired enamel pellicle by mass spectrometry. Arch Oral Biol 46: 293–303. [DOI] [PubMed] [Google Scholar]
  • 16. Vitorino R, Calheiros-Lobo MJ, Duarte JA, Domingues PM, Amado FM (2008) Peptide profile of human acquired enamel pellicle using MALDI tandem MS. J Sep Sci 31: 523–537. [DOI] [PubMed] [Google Scholar]
  • 17. Vitorino R, Calheiros-Lobo MJ, Williams J, Ferrer-Correia AJ, Tomer KB, et al. (2007) Peptidomic analysis of human acquired enamel pellicle. Biomed Chromatogr 21: 1107–1117. [DOI] [PubMed] [Google Scholar]
  • 18. Yao Y, Berg EA, Costello CE, Troxler RF, Oppenheim FG (2003) Identification of protein components in human acquired enamel pellicle and whole saliva using novel proteomics approaches. J Biol Chem 278: 5300–5308. [DOI] [PubMed] [Google Scholar]
  • 19. Siqueira WL, Zhang W, Helmerhorst EJ, Gygi SP, Oppenheim FG (2007) Identification of protein components in in vivo human acquired enamel pellicle using LC-ESI-MS/MS. J Proteome Res 6: 2152–2160. [DOI] [PubMed] [Google Scholar]
  • 20. Iontcheva I, Oppenheim FG, Offner GD, Troxler RF (2000) Molecular mapping of statherin- and histatin-binding domains in human salivary mucin MG1 (MUC5B) by the yeast two-hybrid system. J Dent Res 79: 732–739. [DOI] [PubMed] [Google Scholar]
  • 21. Iontcheva I, Oppenheim FG, Troxler RF (1997) Human salivary mucin MG1 selectively forms heterotypic complexes with amylase, proline-rich proteins, statherin, and histatins. J Dent Res 76: 734–743. [DOI] [PubMed] [Google Scholar]
  • 22. Siqueira WL, Oppenheim FG (2009) Small molecular weight proteins/peptides present in the in vivo formed human acquired enamel pellicle. Arch Oral Biol 54: 437–444. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23. Duan X, Young R, Straubinger RM, Page B, Cao J, et al. (2009) A straightforward and highly efficient precipitation/on-pellet digestion procedure coupled with a long gradient nano-LC separation and Orbitrap mass spectrometry for label-free expression profiling of the swine heart mitochondrial proteome. J Proteome Res 8: 2838–2850. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24. Helmerhorst EJ, Alagl AS, Siqueira WL, Oppenheim FG (2006) Oral fluid proteolytic effects on histatin 5 structure and function. Arch Oral Biol 51: 1061–1070. [DOI] [PubMed] [Google Scholar]
  • 25. Castagnola M, Inzitari R, Rossetti DV, Olmi C, Cabras T, et al. (2004) A cascade of 24 histatins (histatin 3 fragments) in human saliva. Suggestions for a pre-secretory sequential cleavage pathway. The Journal of biological chemistry 279: 41436–41443. [DOI] [PubMed] [Google Scholar]
  • 26. McDonald EE, Goldberg HA, Tabbara N, Mendes FM, Siqueira WL (2011) Histatin 1 resists proteolytic degradation when adsorbed to hydroxyapatite. Journal of Dental Research 90: 268–272. [DOI] [PubMed] [Google Scholar]
  • 27. Helmerhorst EJ, Traboulsi G, Salih E, Oppenheim FG (2010) Mass spectrometric identification of key proteolytic cleavage sites in statherin affecting mineral homeostasis and bacterial binding domains. Journal of proteome research 9: 5413–5421. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28. Oppenheim FG, Salih E, Siqueira WL, Zhang W, Helmerhorst EJ (2007) Salivary proteome and its genetic polymorphisms. Ann N Y Acad Sci 1098: 22–50. [DOI] [PubMed] [Google Scholar]
  • 29. Siqueira WL, Lee YH, Xiao Y, Held K, Wong W (2012) Identification and characterization of histatin 1 salivary complexes by using mass spectrometry. Proteomics 12: 3426–3435. [DOI] [PubMed] [Google Scholar]

Articles from PLoS ONE are provided here courtesy of PLOS

RESOURCES